Analgesic efficacy and safety of paracetamol-codeine combinations versus paracetamol alone: a systematic review. 1996

A J de Craen, and G Di Giulio, and J E Lampe-Schoenmaeckers, and A G Kessels, and J Kleijnen
Department of Clinical Epidemiology and Biostatistics, University of Amsterdam, Netherlands.

OBJECTIVE To assess whether adding codeine to paracetamol has an additive analgesic effect; to assess the safety of paracetamol-codeine combinations versus paracetamol alone. METHODS Systematic literature review with meta-analysis, methodological quality of published trials being scored by means of 13 predefined criteria. METHODS 24 of 29 trials that met the inclusion criteria. Models studied in the trials were postsurgical pain (21), postpartum pain (one), osteoarthritic pain (one), and experimentally induced pain (one). METHODS Dosages ranged from 400 to 1000 mg paracetamol and 10 to 60 mg codeine. METHODS The sum pain intensity difference (efficacy analysis) and the proportion of patients reporting a side effect (safety analysis). RESULTS Most trials were considered of good to very good quality. Only the single dose studies could be combined for analysis of analgesic efficacy. Pooled efficacy results indicated that codeine added to paracetamol provided a 5% increase in analgesia on the sum pain intensity difference. This effect was comparable to the difference in analgesic effect between codeine and placebo. The cumulative incidence of side effects with each treatment was comparable in the single dose trials. In the multidose studies a significantly higher proportion of side effects occurred with paracetamol-codeine preparations. CONCLUSIONS The difference is analgesic effect between paracetamol-codeine combinations and paracetamol alone was small but statistically significant. In the multidose studies the proportion of patients reporting a side effect was significantly higher with paracetamol-codeine combinations. For occasional pain relief a paracetamol-codeine combination might be appropriate but repeated use increases the occurrence of side effects.

UI MeSH Term Description Entries
D010146 Pain An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS. Suffering, Physical,Ache,Pain, Burning,Pain, Crushing,Pain, Migratory,Pain, Radiating,Pain, Splitting,Aches,Burning Pain,Burning Pains,Crushing Pain,Crushing Pains,Migratory Pain,Migratory Pains,Pains, Burning,Pains, Crushing,Pains, Migratory,Pains, Radiating,Pains, Splitting,Physical Suffering,Physical Sufferings,Radiating Pain,Radiating Pains,Splitting Pain,Splitting Pains,Sufferings, Physical
D010147 Pain Measurement Scales, questionnaires, tests, and other methods used to assess pain severity and duration in patients or experimental animals to aid in diagnosis, therapy, and physiological studies. Analgesia Tests,Analogue Pain Scale,Formalin Test,McGill Pain Questionnaire,Nociception Tests,Pain Assessment,Pain Intensity,Pain Severity,Tourniquet Pain Test,Visual Analogue Pain Scale,Analog Pain Scale,Assessment, Pain,McGill Pain Scale,Visual Analog Pain Scale,Analgesia Test,Analog Pain Scales,Analogue Pain Scales,Formalin Tests,Intensity, Pain,Measurement, Pain,Nociception Test,Pain Assessments,Pain Intensities,Pain Measurements,Pain Questionnaire, McGill,Pain Scale, Analog,Pain Scale, Analogue,Pain Scale, McGill,Pain Severities,Pain Test, Tourniquet,Questionnaire, McGill Pain,Scale, Analog Pain,Scale, Analogue Pain,Scale, McGill Pain,Severity, Pain,Test, Analgesia,Test, Formalin,Test, Nociception,Test, Tourniquet Pain,Tests, Nociception,Tourniquet Pain Tests
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003061 Codeine An opioid analgesic related to MORPHINE but with less potent analgesic properties and mild sedative effects. It also acts centrally to suppress cough. Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-,Ardinex,Codeine Phosphate,Isocodeine,N-Methylmorphine,N Methylmorphine
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000082 Acetaminophen Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage. Acetamidophenol,Hydroxyacetanilide,Paracetamol,APAP,Acamol,Acephen,Acetaco,Acetominophen,Algotropyl,Anacin-3,Datril,N-(4-Hydroxyphenyl)acetanilide,N-Acetyl-p-aminophenol,Panadol,Tylenol,p-Acetamidophenol,p-Hydroxyacetanilide,Anacin 3,Anacin3
D000698 Analgesia Methods of PAIN relief that may be used with or in place of ANALGESICS. Analgesias
D000700 Analgesics Compounds capable of relieving pain without the loss of CONSCIOUSNESS. Analgesic,Anodynes,Antinociceptive Agents,Analgesic Agents,Analgesic Drugs,Agents, Analgesic,Agents, Antinociceptive,Drugs, Analgesic

Related Publications

A J de Craen, and G Di Giulio, and J E Lampe-Schoenmaeckers, and A G Kessels, and J Kleijnen
November 1996, BMJ (Clinical research ed.),
A J de Craen, and G Di Giulio, and J E Lampe-Schoenmaeckers, and A G Kessels, and J Kleijnen
April 1968, The Practitioner,
A J de Craen, and G Di Giulio, and J E Lampe-Schoenmaeckers, and A G Kessels, and J Kleijnen
November 1996, BMJ (Clinical research ed.),
A J de Craen, and G Di Giulio, and J E Lampe-Schoenmaeckers, and A G Kessels, and J Kleijnen
November 1996, BMJ (Clinical research ed.),
A J de Craen, and G Di Giulio, and J E Lampe-Schoenmaeckers, and A G Kessels, and J Kleijnen
June 2020, Pain and therapy,
A J de Craen, and G Di Giulio, and J E Lampe-Schoenmaeckers, and A G Kessels, and J Kleijnen
January 2015, European review for medical and pharmacological sciences,
A J de Craen, and G Di Giulio, and J E Lampe-Schoenmaeckers, and A G Kessels, and J Kleijnen
January 1987, The Journal of international medical research,
A J de Craen, and G Di Giulio, and J E Lampe-Schoenmaeckers, and A G Kessels, and J Kleijnen
January 1987, The Journal of international medical research,
A J de Craen, and G Di Giulio, and J E Lampe-Schoenmaeckers, and A G Kessels, and J Kleijnen
June 1982, Medizinische Klinik (Praxis-Ausg.),
A J de Craen, and G Di Giulio, and J E Lampe-Schoenmaeckers, and A G Kessels, and J Kleijnen
August 1996, Journal of clinical pharmacy and therapeutics,
Copied contents to your clipboard!